siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin
Pancreatic cancer is currently one of the deadliest of the solid malignancies, whose incidence and death rates are increasing consistently during the past 30 years. Ribonucleotide reductase (RR) is a rate-limiting enzyme that catalyzes the formation of deoxyribonucleotides from ribonucleotides, whic...
Saved in:
Main Authors: | Shuquan Zheng (Author), Xiaoxia Wang (Author), Yu-Hua Weng (Author), Xingyu Jin (Author), Jia-Li Ji (Author), Liangxia Guo (Author), Bo Hu (Author), Nan Liu (Author), Qiang Cheng (Author), Jianqi Zhang (Author), Huicheng Bai (Author), Tongren Yang (Author), Xin-Hua Xia (Author), Hong-Yan Zhang (Author), Shan Gao (Author), Yuanyu Huang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma
by: Khushbu Khetan, et al.
Published: (2021) -
Oxymatrine Synergistically Enhances Doxorubicin Anticancer Effects in Colorectal Cancer
by: Di Pan, et al.
Published: (2021) -
Synergistic Effect of Doxorubicin and siRNA-Mediated Silencing of Mcl-1 Using Cationic Niosomes against 3D MCF-7 Spheroids
by: Supusson Pengnam, et al.
Published: (2021) -
Targeted siRNA Delivery and mRNA Knockdown Mediated by Bispecific Digoxigenin-binding Antibodies
by: Britta Schneider, et al.
Published: (2012) -
Case Report: A novel RRM2B variant in a Chinese infant with mitochondrial DNA depletion syndrome and collective analyses of RRM2B variants for disease etiology
by: Yanjun Wang, et al.
Published: (2024)